Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
OmniaBioomniabio.com · Low evidenceOmniaBio is a cell and gene therapy contract development and manufacturing organization (CDMO) that provides process development, analytical development, and GMP manufacturing services for autologous and allogeneic therapies. The company integrates AI, automation, and robotics to offer scalable, compliant manufacturing solutions from preclinical development through commercial supply.
Parse Score